Li M - Search Results

1

Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect.

Zhang Q, Qin Y, Zhao J, Tang Y, Hu X, Zhong W, Li M, Zong S, Li M, Tao H, Zhang Z, Chen S, Liu H, Yang L, Zhou H, Liu Y, Sun T, Yang C. Zhang Q, et al. Among authors: li m. Cell Death Dis. 2019 Jan 17;10(2):43. doi: 10.1038/s41419-018-1282-6. Cell Death Dis. 2019. PMID: 30674871 Free PMC article.

2

Correction: Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect.

Zhang Q, Qin Y, Zhao J, Tang Y, Hu X, Zhong W, Li M, Zong S, Li M, Tao H, Zhang Z, Chen S, Liu H, Yang L, Zhou H, Liu Y, Sun T, Yang C. Zhang Q, et al. Among authors: li m. Cell Death Dis. 2022 Feb 9;13(2):134. doi: 10.1038/s41419-022-04557-7. Cell Death Dis. 2022. PMID: 35140197 Free PMC article. No abstract available.

3

Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.

Zhang Q, Zhang Y, Hu X, Qin Y, Zhong W, Meng J, Xiao T, Zhang C, Li M, Chen S, Liu H, Liu Y, Sun T, Yang C. Zhang Q, et al. Among authors: li m. Lab Invest. 2017 Aug;97(8):903-912. doi: 10.1038/labinvest.2017.51. Epub 2017 May 22. Lab Invest. 2017. PMID: 28530649 Free article.

4

Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.

Liu Y, Zhao J, Zhao Y, Zong S, Tian Y, Chen S, Li M, Liu H, Zhang Q, Jing X, Sun B, Wang H, Sun T, Yang C. Liu Y, et al. Among authors: li m. J Cell Mol Med. 2019 Feb;23(2):750-760. doi: 10.1111/jcmm.13897. Epub 2018 Nov 24. J Cell Mol Med. 2019. PMID: 30472806 Free PMC article.

5

Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota.

Liu H, Qin Y, Li K, Li M, Yang J, Tao H, Tang Y, Yang L, Chen S, Liu Y, Yang C, Gao W, Sun T. Liu H, et al. Among authors: li m, li k. Br J Pharmacol. 2021 Feb;178(4):946-963. doi: 10.1111/bph.15338. Epub 2021 Jan 13. Br J Pharmacol. 2021. PMID: 33284460 Free article.

6

Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters.

Liu YR, Liang L, Zhao JM, Zhang Y, Zhang M, Zhong WL, Zhang Q, Wei JJ, Li M, Yuan J, Chen S, Zong SM, Liu HJ, Meng J, Qin Y, Sun B, Yang L, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: li m. Oncotarget. 2017 May 2;8(32):52901-52912. doi: 10.18632/oncotarget.17548. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881781 Free PMC article.

7

Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.

Liu YR, Sun B, Zhu GH, Li WW, Tian YX, Wang LM, Zong SM, Sheng PZ, Li M, Chen S, Qin Y, Liu HJ, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: li ww, li m. Toxicol Appl Pharmacol. 2018 Dec 1;360:1-8. doi: 10.1016/j.taap.2018.09.019. Epub 2018 Sep 18. Toxicol Appl Pharmacol. 2018. PMID: 30240696

8

Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway.

Qin Y, Liu HJ, Li M, Zhai DH, Tang YH, Yang L, Qiao KL, Yang JH, Zhong WL, Zhang Q, Liu YR, Yang G, Sun T, Yang C. Qin Y, et al. Among authors: li m. EBioMedicine. 2018 Dec;38:25-36. doi: 10.1016/j.ebiom.2018.10.069. Epub 2018 Nov 2. EBioMedicine. 2018. PMID: 30396856 Free PMC article.

9

Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].

Liu YR, Sun B, Zhu GH, Li WW, Tian YX, Wang LM, Zong SM, Sheng PZ, Li M, Chen S, Qin Y, Liu HJ, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: li ww, li m. Toxicol Appl Pharmacol. 2022 Jan 15;435:115824. doi: 10.1016/j.taap.2021.115824. Epub 2021 Dec 8. Toxicol Appl Pharmacol. 2022. PMID: 34890639 No abstract available.

10

Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicology and Applied Pharmacology 360 (2018) 1-8].

Liu YR, Sun B, Zhu GH, Li WW, Tian YX, Wang LM, Zong SM, Sheng PZ, Li M, Chen S, Qin Y, Liu HJ, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: li ww, li m. Toxicol Appl Pharmacol. 2022 Nov 15;455:116261. doi: 10.1016/j.taap.2022.116261. Epub 2022 Sep 28. Toxicol Appl Pharmacol. 2022. PMID: 36179858 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,432 results

Search Page